Movement Alert｜REVVITY INC Rises 5.16% in Regular Trading, Q2 Earnings Significantly Beat Expectations with Sector-Wide Strength

Market Focus

Aug 20

On August 20, REVVITY INC rose 5.16% in regular trading, trading at $119.25/share, with turnover of $98.71 million.

On the news front, the company's Q2 earnings report released earlier significantly exceeded market expectations. Adjusted EPS came in at $1.41, beating the consensus estimate of $1.22 by 15.57%, representing a 19.49% year-over-year increase. Revenue of $729.7 million also surpassed the $709 million estimate. Management raised full-year guidance, projecting adjusted EPS of $5.30-$5.40, above the prior FactSet estimate of $5.24, with revenue guidance of $2.83-$2.86 billion. Evercore ISI subsequently raised its price target to $126, maintaining an Outperform rating.

Management noted improving biotech client demand and growing AI-related orders as incremental growth drivers, while expressing greater optimism for the second half given favorable diagnostics trends. The broader Life Sciences Tools and Services sector rallied in tandem, with Illumina up 8.0%, Repligen up 6.02%, and Danaher up 5.5%, providing additional momentum.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1155007631"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1155007631\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1155007631?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-20 01:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1155007631","market":"us","top_or_hot":-1,"title":"Movement Alert｜REVVITY INC Rises 5.16% in Regular Trading, Q2 Earnings Significantly Beat Expectations with Sector-Wide Strength","media":"Market Focus","content":"<p><p>On August 20, REVVITY INC rose 5.16% in regular trading, trading at $119.25/share, with turnover of $98.71 million.</p><p>On the news front, the company's Q2 earnings report released earlier significantly exceeded market expectations. Adjusted EPS came in at $1.41, beating the consensus estimate of $1.22 by 15.57%, representing a 19.49% year-over-year increase. Revenue of $729.7 million also surpassed the $709 million estimate. Management raised full-year guidance, projecting adjusted EPS of $5.30-$5.40, above the prior FactSet estimate of $5.24, with revenue guidance of $2.83-$2.86 billion. Evercore ISI subsequently raised its price target to $126, maintaining an Outperform rating.</p><p>Management noted improving biotech client demand and growing AI-related orders as incremental growth drivers, while expressing greater optimism for the second half given favorable diagnostics trends. The broader Life Sciences Tools and Services sector rallied in tandem, with Illumina up 8.0%, Repligen up 6.02%, and Danaher up 5.5%, providing additional momentum.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜REVVITY INC Rises 5.16% in Regular Trading, Q2 Earnings Significantly Beat Expectations with Sector-Wide Strength</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜REVVITY INC Rises 5.16% in Regular Trading, Q2 Earnings Significantly Beat Expectations with Sector-Wide Strength\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-20 01:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 20, REVVITY INC rose 5.16% in regular trading, trading at $119.25/share, with turnover of $98.71 million.</p><p>On the news front, the company's Q2 earnings report released earlier significantly exceeded market expectations. Adjusted EPS came in at $1.41, beating the consensus estimate of $1.22 by 15.57%, representing a 19.49% year-over-year increase. Revenue of $729.7 million also surpassed the $709 million estimate. Management raised full-year guidance, projecting adjusted EPS of $5.30-$5.40, above the prior FactSet estimate of $5.24, with revenue guidance of $2.83-$2.86 billion. Evercore ISI subsequently raised its price target to $126, maintaining an Outperform rating.</p><p>Management noted improving biotech client demand and growing AI-related orders as incremental growth drivers, while expressing greater optimism for the second half given favorable diagnostics trends. The broader Life Sciences Tools and Services sector rallied in tandem, with Illumina up 8.0%, Repligen up 6.02%, and Danaher up 5.5%, providing additional momentum.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RVTY","symbol_name":"REVVITY INC","start_time":0,"source_url":"","article_id":"1155007631","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1155007631","pubTimestamp":1787161182,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 20, REVVITY INC rose 5.16% in regular trading, trading at $119.25/share, with turnover of $98.71 million.On the news front, the company's Q2 earnings report released earlier significantly...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RVTY":"REVVITY INC"},"translate_title":"走势警报|REVVITY INC 常规交易中上涨 5.16%，第二季度盈利大幅超出预期，全行业走强","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RVTY":1},"content_text":"On August 20, REVVITY INC rose 5.16% in regular trading, trading at $119.25/share, with turnover of $98.71 million.On the news front, the company's Q2 earnings report released earlier significantly exceeded market expectations. Adjusted EPS came in at $1.41, beating the consensus estimate of $1.22 by 15.57%, representing a 19.49% year-over-year increase. Revenue of $729.7 million also surpassed the $709 million estimate. Management raised full-year guidance, projecting adjusted EPS of $5.30-$5.40, above the prior FactSet estimate of $5.24, with revenue guidance of $2.83-$2.86 billion. Evercore ISI subsequently raised its price target to $126, maintaining an Outperform rating.Management noted improving biotech client demand and growing AI-related orders as incremental growth drivers, while expressing greater optimism for the second half given favorable diagnostics trends. The broader Life Sciences Tools and Services sector rallied in tandem, with Illumina up 8.0%, Repligen up 6.02%, and Danaher up 5.5%, providing additional momentum.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}